Inactive Instrument

Highlights Cytokinetics, Inc. Nasdaq

Equities

US23282W1009

End-of-day quote Nasdaq Other stock markets
- ^USD	-

15/05	Transcript : Cytokinetics, Incorporated - Shareholder/Analyst Call
13/05	Transcript : Cytokinetics, Incorporated - Special Call

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytokinetics Q1 Net Loss Narrows, Revenue Declines	09/05	MT
Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Posts Q1 Revenue $835,000, vs. Street Est of $0.9M	09/05	MT
Cytokinetics, Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
Cytokinetics, Incorporated Announces Topline Data from Phase 1 Clinical Study of Ck-4021586	08/05	CI
Cytokinetics, Incorporated Announces CEDAR-HCM Is Open to Enrollment	08/05	CI
Sector Update: Health Care Stocks Rise Friday Afternoon	05/04	MT
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise	05/04	MT
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session	05/04	CI
Cytokinetics Q4 Net Loss Narrows, Revenue Decreases; 2024 Outlook Issued	28/02	MT
Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Reports Q4 Revenue $1.7M, vs. Street Est of $13.3M	28/02	MT
Cytokinetics, Incorporated Provides Revenue Guidance for 2024	28/02	CI
Cytokinetics, Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
Cytokinetics, Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02	CI
Novartis Interest in Cytokinetics Takeover Has Cooled	12/01	MT
Correction: Market Chatter: Novartis Interest in Cytokinetics Takeover Has Cooled	12/01	MT
Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal	11/01	DJ
Novartis drops pursuit of Cytokinetics - WSJ	11/01	RE
Novartis Pursuit of Cytokinetics Reportedly Cools	11/01	CI
Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal	08/01	DJ
Novartis Reportedly in Advanced Talks to Buy Cytokinetics, Deal Possible This Week	08/01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cytokinetics, Inc. Nasdaq

Equities

US23282W1009

Highlights

Filters